Position in VRTX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$188,948,935
-$6,568,005 QoQ
Shares Held
423,140
-1.9% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 59.97258590537411.ToString("F0")%
Shared 0.ToString("F0")%
None 40.02741409462589.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,238,262,141 across 282 Biotechnology names. VRTX ranks #1 (15.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $188,948,935 | 423,140 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $195,516,940 | 431,262 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $175,426,521 | 447,928 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $202,286,414 | 454,372 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $218,668,849 | 451,031 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $178,138,774 | 442,361 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $209,144,615 | 449,696 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $214,629,231 | 457,905 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $193,633,518 | 463,227 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $186,554,182 | 458,488 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $161,264,772 | 463,751 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $163,049,052 | 463,326 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $141,917,295 | 450,431 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $123,233,110 | 426,737 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $118,185,305 | 408,183 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $111,587,431 | 395,995 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $98,990,096 | 379,316 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $86,141,613 | 392,266 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $69,884,850 | 385,274 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $80,804,432 | 400,756 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $108,873,158 | 506,646 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $123,429,037 | 522,252 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $141,477,092 | 519,907 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $154,608,654 | 532,564 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $119,923,468 | 503,986 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||